Inflammatory and oxidative stress signaling pathways in cardiovascular tissues

Inflammatory and oxidative stress signaling pathways in cardiovascular tissues represent a complex network of interconnected biochemical processes that drive the progression of various heart and vascular diseases. These pathways involve the production of reactive oxygen species (ROS) and the activation of pro-inflammatory mediators, which together promote endothelial dysfunction, vascular smooth muscle cell proliferation, and myocardial remodeling (PubMed: 29435113). Key molecular players often include the NADPH oxidase (NOX) family, the transcription factor NF-kappaB, and various cytokines such as TNF-alpha and IL-6 (NIH: PMC5839371). While not a single therapeutic target, these pathways are modulated by several classes of cardiovascular drugs, including statins, ACE inhibitors, and specific anti-inflammatory agents like colchicine, which aim to reduce the chronic low-grade inflammation and oxidative damage associated with atherosclerosis and heart failure (StatPearls: NBK470444). Furthermore, the integration of these pathways often leads to a self-perpetuating cycle where oxidative stress triggers inflammation, which in turn generates more ROS, exacerbating tissue injury (PubMed: 29435113). Understanding the crosstalk between these signals is crucial for developing targeted therapies that can selectively inhibit pathological signaling without disrupting essential physiological redox homeostasis (PubMed: 31730347).

Other names

Cardiovascular inflammatory pathwaysOxidative stress signaling in heartRedox signaling in vasculatureInflammatory-oxidative stress axisRedox-inflammatory signaling

Inhibition of pro-inflammatory cytokine production, neutralization of reactive oxygen species, and stabilization of mitochondrial function to prevent oxidative damage and downstream inflammatory signaling (PubMed: 29435113).